Care of the Elderly Resources

Search Knowledge Base by Keyword

Session 10: Movement Disorders

You are here:
< Back


  1. Fernandez HH. 2015 Update on Parkinson disease. Cleve Clin J Med. 2015;82(9):563-568. doi:10.3949/ccjm.82gr.15004

  2. Grimes D, Gordon J, Snelgrove B, et al. Canadian Guidelines on Parkinson’s Disease. Can J Neurol Sci. 2012;39(4 Suppl 4):S1-S30. doi:10.1017/s031716710001516x

  3. Olanow CW, Kieburtz K, Odin P, et al. Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson’s disease: a randomised, controlled, double-blind, double-dummy study [published correction appears in Lancet Neurol. 2014 Mar;13(3):240]. Lancet Neurol. 2014;13(2):141-149. doi:10.1016/S1474-4422(13)70293-X

  4. Postuma RB, Berg D, Stern M, et al. MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord. 2015;30(12):1591-1601. doi:10.1002/mds.26424

  5. McLean G, Lawrence M, Simpson R, Mercer SW. Mindfulness-based stress reduction in Parkinson’s disease: a systematic review. BMC Neurol. 2017;17(1):92. Published 2017 May 15. doi:10.1186/s12883-017-0876-4

  6. Goetz CG, Tilley BC, Shaftman SR, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord. 2008;23(15):2129-2170. doi:10.1002/mds.22340

  7. Jankovic J. Parkinson’s disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry. 2008;79(4):368-376. doi:10.1136/jnnp.2007.131045

  8. Gratwicke J, Jahanshahi M, Foltynie T. Parkinson’s disease dementia: a neural networks perspective. Brain. 2015;138(Pt 6):1454-1476. doi:10.1093/brain/awv104

  9. Cacabelos R. Parkinson’s Disease: From Pathogenesis to Pharmacogenomics. Int J Mol Sci. 2017;18(3):551. Published 2017 Mar 4. doi:10.3390/ijms18030551

  10. Lewis SJ, Gangadharan S, Padmakumar CP. Parkinson’s disease in the older patient. Clin Med (Lond). 2016;16(4):376-378. doi:10.7861/clinmedicine.16-4-376

  11. Gisbert R, Schenkman M. Physical therapist interventions for Parkinson disease [published correction appears in Phys Ther. 2015 Apr;95(4):685]. Phys Ther. 2015;95(3):299-305. doi:10.2522/ptj.20130334

  12. Saltychev M, Bärlund E, Paltamaa J, Katajapuu N, Laimi K. Progressive resistance training in Parkinson’s disease: a systematic review and meta-analysis. BMJ Open. 2016;6(1):e008756. Published 2016 Jan 7. doi:10.1136/bmjopen-2015-008756

  13. Ramazzina I, Bernazzoli B, Costantino C. Systematic review on strength training in Parkinson’s disease: an unsolved question. Clin Interv Aging. 2017;12:619-628. Published 2017 Mar 31. doi:10.2147/CIA.S131903

  14. Antony PM, Diederich NJ, Krüger R, Balling R. The hallmarks of Parkinson’s disease. FEBS J. 2013;280(23):5981-5993. doi:10.1111/febs.12335

  15. Seppi K, Weintraub D, Coelho M, et al. The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson’s disease. Mov Disord. 2011;26 Suppl 3(0 3):S42-S80. doi:10.1002/mds.23884

  16. Mehrholz J, Kugler J, Storch A, Pohl M, Hirsch K, Elsner B. Treadmill training for patients with Parkinson’s disease. Cochrane Database Syst Rev. 2015;(9):CD007830. Published 2015 Sep 13. doi:10.1002/14651858.CD007830.pub4

  17. Connolly B, Fox SH. Treatment of cognitive, psychiatric, and affective disorders associated with Parkinson’s disease. Neurotherapeutics. 2014;11(1):78-91. doi:10.1007/s13311-013-0238-x